UNCOMMON SIDE EFFECTS OF SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CANCER: CASE REPORT

SUMMARY – Sunitinib is an orally administered multikinase inhibitor. This therapy can provoke uncommon side effects such as pancytopenia, tumor lysis syndrome, cardiac disorders, thromboembolic incidents, intestinal perforation, pancreatitis, acute renal failure, etc. We report a case of a 63-year-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Šeparović, Robert, Pavlović, Mirjana, Silovski, Tajana, Silovski, Hrvoje, Tečić Vuger, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536270/
https://www.ncbi.nlm.nih.gov/pubmed/31168192
http://dx.doi.org/10.20471/acc.2018.57.03.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536270/
https://www.ncbi.nlm.nih.gov/pubmed/31168192
http://dx.doi.org/10.20471/acc.2018.57.03.22

Ejemplares similares